NASDAQ:LENZ

Lenz Therapeutics Stock Forecast

etoro logo Buy LENZ
*Your capital is at risk
$5.48
+0.430 (+8.51%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of LENZ AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add LENZ to Watchlist?
Some Reasons Why To Add LENZ:
  • High gross margin of 91.2%
  • Beat earnings estimates in 3 of the last 4 quarters
  • Highly efficient cash conversion (101% FCF/OCF ratio)
PDF

On Friday, Lenz Therapeutics, Inc. stock price gained an impressive 8.51%
(Updated on Jul 24, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jul 24, 2026

The Lenz Therapeutics, Inc. stock price gained 8.51% on the last trading day (Friday, 24th Jul 2026), rising from $5.05 to $5.48. During the last trading day the stock fluctuated 9.34% from a day low at $5.03 to a day high of $5.50. The price has been going up and down for this period, and there has been a -1.97% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 816 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $7.83 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -43.04% during the next 3 months and, with a 90% probability hold a price between $2.52 and $3.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LENZ Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has risen 12.30%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lenz Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.86. On a fall, the stock will find some support from the short-term average at $5.15. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Lenz Therapeutics, Inc. stock

Lenz Therapeutics, Inc. finds support from accumulated volume at $5.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.470 between high and low, or 9.34%. For the last week, the stock has had daily average volatility of 7.05%.

Our recommended stop-loss: $5.26 (-4.04%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (LENZ) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Lenz Therapeutics, Inc. to open at $5.34, and during the day (based on 14 day Average True Range), to move between $5.27 and $5.69, which gives a possible trading interval of +/-$0.414 (+/-7.84%) up or down from last closing price. If Lenz Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.23 (4.56%) than the resistance at $5.79 (5.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Lenz Therapeutics, Inc. will release earnings on Wednesday, July 29, 2026.The consensus among the analysts for the expected earnings (EPS) is -$1.07. We will update the financials statements for Lenz Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.93% in the first trading day after earnings release.

Is Lenz Therapeutics, Inc. stock A Buy?

Lenz Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.062 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $5.34 ( 2.62%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

LENZ Performance

Trading levels for LENZ

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 5.81 5.96%
R2 5.63 2.68%
R1 5.52 0.661%
Price 5.48
S1 5.16 -5.89%
S2 5.05 -7.92%
S3 4.87 -11.19%

Accumulated Volume Support & Resistance Levels

Level Price
R3 5.90 7.66%
R2 5.82 6.20%
R1 5.79 5.66%
Price 5.48
S1 5.23 -4.56%
S2 4.93 -10.04%
S3 4.88 -10.95%

LENZ Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 22, 2024 Mar 22, 2024 Mar 22, 2024 $7.21 44.51%
2 Mar 15, 2024 Mar 15, 2024 Mar 15, 2024 $7.21 45.60%

FAQ

What is the symbol for Lenz Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Lenz Therapeutics, Inc. is LENZ and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lenz Therapeutics, Inc. Stock?
Lenz Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Lenz Therapeutics, Inc. Stock?
Lenz Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lenz Therapeutics, Inc. Stock.

What's the current price of Lenz Therapeutics, Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Lenz Therapeutics, Inc. (LENZ) share was $5.48.

What is the 52-week high and low for Lenz Therapeutics, Inc. Stock?
The 52-week high for Lenz Therapeutics, Inc. Stock is $50.19 and the 52-week low is $4.68.

What is the market capitalization of Lenz Therapeutics, Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Lenz Therapeutics, Inc. is 171.822M.

When is the next earnings date for Lenz Therapeutics, Inc.?
The upcoming earnings date for Lenz Therapeutics, Inc. is Jul 29, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
ROP
$331.60
10.78% Jun 24
JLL
$299.78
8.56% Jun 24
NMRK
$15.02
2.46% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE